14th Kempen Life Sciences Conference

C21 shows promise against COVID-19 where other drugs have failed

Report on the ATTRACT study

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Patient insights to shape development of a dCBT for IPF patients

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients